AU4980100A - Compositions containing benzimidazolones and progestogens - Google Patents
Compositions containing benzimidazolones and progestogensInfo
- Publication number
- AU4980100A AU4980100A AU49801/00A AU4980100A AU4980100A AU 4980100 A AU4980100 A AU 4980100A AU 49801/00 A AU49801/00 A AU 49801/00A AU 4980100 A AU4980100 A AU 4980100A AU 4980100 A AU4980100 A AU 4980100A
- Authority
- AU
- Australia
- Prior art keywords
- benzimidazolones
- progestogens
- compositions containing
- compositions
- containing benzimidazolones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60198249 | 1999-05-04 | ||
US09552355 | 2000-04-19 | ||
US09/552,355 US6423699B1 (en) | 1999-05-04 | 2000-04-19 | Combination therapies using benzimidazolones |
PCT/US2000/011845 WO2000066168A1 (en) | 1999-05-04 | 2000-05-01 | Compositions containing benzimidazolones and progestogens |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4980100A true AU4980100A (en) | 2000-11-17 |
Family
ID=24204973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU49801/00A Abandoned AU4980100A (en) | 1999-05-04 | 2000-05-01 | Compositions containing benzimidazolones and progestogens |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1173213A1 (en) |
AU (1) | AU4980100A (en) |
WO (1) | WO2000066168A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2003001544A1 (en) | 2002-10-11 | 2005-01-07 | Ligand Pharm Inc | COMPOUNDS DERIVED FROM 5-CICLOALQUENIL-5H-CHROMENE [3,4-F] FORMULA QUINOLINE I, SELECTIVE MODULATORS OF THE PROGESTERONE RECEIVER; PHARMACEUTICAL COMPOSITION; AND ITS USE IN THE TREATMENT OF DYSFUNCTIONAL UTERINE BLEEDING, DISMENORREA, ENDOMETRIOSIS, L |
AR040783A1 (en) | 2002-10-11 | 2005-04-20 | Ligand Pharm Inc | 5- (1 ', 1'-CYCLOAQUIL / ALQUENIL) METHYLIDEN-1,2-DIHYDRO-5-H-CHROMENE [3,4- F] CHIINOLINES AS SELECTING MODULATING COMPOUNDS OF PROGESTERONE RECEPTORS |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3733478A1 (en) * | 1987-10-01 | 1989-04-13 | Schering Ag | ANTIGESTAGEN AND ANTIOOTROGENIC COMPOUNDS FOR THE INTRODUCTION OF BIRTH AND PREGNANCY, AND THE TREATMENT OF GYNAECOLOGICAL DISORDER AND HORMONE-RELATED TUMORS |
DE4330234A1 (en) * | 1993-09-02 | 1995-03-09 | Schering Ag | The use of progestogens and competitive progesterone antagonists for the production of pharmaceuticals for female fertility control and compositions comprising a progestogen and a competitive progesterone antagonist |
DE4344463A1 (en) * | 1993-12-22 | 1995-06-29 | Schering Ag | Combination product for contraception |
DK0792152T3 (en) * | 1994-11-22 | 2004-07-12 | Balance Pharmaceuticals Inc | Procedures for Pregnancy Prevention |
US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
US5696133A (en) * | 1994-12-22 | 1997-12-09 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
AU725670B2 (en) * | 1996-06-25 | 2000-10-19 | Akzo Nobel N.V. | Progestogen-anti-progestogen regimens |
-
2000
- 2000-05-01 WO PCT/US2000/011845 patent/WO2000066168A1/en not_active Application Discontinuation
- 2000-05-01 AU AU49801/00A patent/AU4980100A/en not_active Abandoned
- 2000-05-01 EP EP00932006A patent/EP1173213A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1173213A1 (en) | 2002-01-23 |
WO2000066168A1 (en) | 2000-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3731600A (en) | Composition and structures made therefrom | |
AU2001290257A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
AU2001290257A2 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
AU3233400A (en) | Fire suppression composition and device | |
HUP0200797A3 (en) | Releasable linkage and compositions containing same | |
AU5634300A (en) | Composition and films thereof | |
AU4198299A (en) | Compounds and uses thereof | |
AU2349399A (en) | R-lansoprazole compositions and methods | |
AU5565099A (en) | Pharmaceutical compositions and methods for use | |
AU1403501A (en) | Novel composition and use | |
AU7651100A (en) | Pharmaceutical and/or cosmetical compositions | |
AU2001292047A1 (en) | Composition containing an azaphthalocyanine and use | |
MXPA01011309A (en) | Compositions containing benzimidazolones and progestogens. | |
HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
AU4834200A (en) | Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof | |
AU7853700A (en) | Foams and compositions containing these foams | |
AU7816000A (en) | Pediculocidal and veterinary compositions | |
AU5384699A (en) | Basic peptides and pharmaceutical compositions containing same | |
AU6297700A (en) | Organometallic compositions and polyisocyanate compositions containing them | |
AU1152601A (en) | Compositions and their use | |
IL146047A0 (en) | Releasable linkage and compositions containing same | |
AU2183899A (en) | Isoflavane derivatives and immunopotentiating compositions containing the same | |
AU4543500A (en) | Pharmaceutical compositions and uses | |
AU4980100A (en) | Compositions containing benzimidazolones and progestogens | |
AU5979300A (en) | Angiopoietin-6 and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |